Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BETOPTIC PILO

BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE

Standard Dose
EQ 0.25% BASE;1.75%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BETOPTIC PILO is listed in Drugs@FDA under application 020619 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 0.25% BASE;1.75% Sponsor ALCON Submission history Latest submission status date: 1997-04-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview BETOPTIC PILO is listed in Drugs@FDA under application 020619 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 0.25% BASE;1.75% Sponsor ALCON Submission history Latest submission status date: 1997-04-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
BETOPTIC PILO (BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline